https://scholars.lib.ntu.edu.tw/handle/123456789/531295
標題: | Long-term effects of medical management on growth and weight in individuals with urea cycle disorders | 作者: | Posset R. Garbade S.F. Gleich F. Gropman A.L. de Lonlay P. Hoffmann G.F. Garcia-Cazorla A. Nagamani S.C.S. Baumgartner M.R. Schulze A. Dobbelaere D. Yudkoff M. K?lker S. Zielonka M. Ah?Mew N. Berry S.A. McCandless S.E. Coughlin C. Enns G. Gallagher R.C. Burrage L.C. Seminara J. Harding C.O. Burgard P. Le?Mons C. Merritt J.L. II, Stricker T. Bedoyan J.K. Berry G.T. Diaz G.A. Wong D. Tuchman M. Waisbren S. Weisfeld-Adams J.D. Burlina A.B. Le?o?Teles E. Pedr?n-Giner C. Lund A.M. Dionisi-Vici C. Williams M. M?tze U. Karall D. Blasco-Alonso J. Couce M.L. Sykut-Cegielska J. Augoustides-Savvopoulou P. Ruiz?Gomez A. Bari? I. Schiff M. YIN-HSIU CHIEN Lindner M. Chabrol B. Skouma A. Zeman J. Sokal E. Santer R. Eyskens F. Freisinger P. Pe?a-Quintana L. Roland D. Cort?s-Saladelafont E. Djordjevic M. Urea Cycle Disorders Consortium (UCDC), European registry network for Intoxication type Metabolic Diseases (E-IMD) |
公開日期: | 2020 | 出版社: | Nature Research | 卷: | 10 | 期: | 1 | 起(迄)頁: | 11948 | 來源出版物: | Scientific Reports | 摘要: | Low protein diet and sodium or glycerol phenylbutyrate, two pillars of recommended long-term therapy of individuals with urea cycle disorders (UCDs), involve the risk of iatrogenic growth failure. Limited evidence-based studies hamper our knowledge on the long-term effects of the proposed medical management in individuals with UCDs. We studied the impact of medical management on growth and weight development in 307 individuals longitudinally followed by the Urea Cycle Disorders Consortium (UCDC) and the European registry and network for Intoxication type Metabolic Diseases (E-IMD). Intrauterine growth of all investigated UCDs and postnatal linear growth of asymptomatic individuals remained unaffected. Symptomatic individuals were at risk of progressive growth retardation independent from the underlying disease and the degree of natural protein restriction. Growth impairment was determined by disease severity and associated with reduced or borderline plasma branched-chain amino acid (BCAA) concentrations. Liver transplantation appeared to have a beneficial effect on growth. Weight development remained unaffected both in asymptomatic and symptomatic individuals. Progressive growth impairment depends on disease severity and plasma BCAA concentrations, but cannot be predicted by the amount of natural protein intake alone. Future clinical trials are necessary to evaluate whether supplementation with BCAAs might improve growth in UCDs. ? 2020, The Author(s). |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088256000&doi=10.1038%2fs41598-020-67496-3&partnerID=40&md5=76b04987db0b9c07a08cd72bcebf3441 https://scholars.lib.ntu.edu.tw/handle/123456789/531295 |
ISSN: | 2045-2322 | DOI: | 10.1038/s41598-020-67496-3 | SDG/關鍵字: | biological marker; body weight; child; disease management; factual database; female; health survey; human; human development; infant; male; preschool child; standard; symptom assessment; urea cycle disorder; Biomarkers; Body Weight; Child; Child, Preschool; Databases, Factual; Disease Management; Female; Human Development; Humans; Infant; Male; Public Health Surveillance; Symptom Assessment; Urea Cycle Disorders, Inborn; Weights and Measures |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。